Page 3 - Pharma Stocks
Lupin shares jump 4% on new Florida manufacturing facility plan
Lupin said the project aims to boost medicine security, diversify supply chains, and reinforce its position as a global leader in respiratory therapies
 "Lupin shares jump 4% on new Florida manufacturing facility plan")
Rubicon Research IPO opens Oct 9; key risks, strengths you must know
Rubicon Research IPO is available at a price band of ₹461-485 per share, with a lot size of 30 shares
 "Rubicon Research IPO opens Oct 9; key risks, strengths you must know")
Nifty Pharma down 2.5% as Trump slaps 100% import tariffs; impact decoded
Among individual counters, Sun Pharma slumped 4.87 per cent to a fresh 52-week low of ₹1,548, while Gland Pharma tumbled 4.70 per cent to ₹1,880. Biocon declined 3.68 per cent to ₹342.85.
 "Nifty Pharma down 2.5% as Trump slaps 100% import tariffs; impact decoded")
Asia stocks slide as Trump slaps new pharma tariffs, Fed cut bets recede
Shares of pharmaceutical companies across Asia tumbled in the aftermath, with Japan's Topix pharmaceutical index last down 1.2 per cent, while Hong Kong-listed innovative drug index fell 2 per cent
 "Asia stocks slide as Trump slaps new pharma tariffs, Fed cut bets recede")
Dr Reddy's, Sun: Pharma stocks can crash up to 30% on Trump's 100% tariff
Indian pharma shares - Dr.Reddy's, Cipla, Sun, Lupin and Aurobindo Pharma stare at up to 30 downside risk hint technical charts as US President Donald Trump announces 100% tariff on pharma imports.
 "Dr Reddy's, Sun: Pharma stocks can crash up to 30% on Trump's 100% tariff")
Stocks to Watch today, Sept 26: Pharma, IT, auto, Polycab, Rites, Eternal
Stocks to Watch today, September 26, 2025: From Pharma, auto to Polycab, here is a list of stocks that will be in focus
 "Stocks to Watch today, Sept 26: Pharma, IT, auto, Polycab, Rites, Eternal")
Why Nomura continues to back Glenmark Pharma; Retains 'Buy'; Find out here
Analysts at Nomura continue to back Glenmark Pharma, citing the company's ability to strategically acquire high-potential innovative products.
 "Why Nomura continues to back Glenmark Pharma; Retains 'Buy'; Find out here")
Sun Pharmaceutical: Domestic, innovation push eyed; Nuvama maintains 'Hold'
Sun Pharma aims to strengthen its domestic formulations business through field force expansion and a generic GLP-1 launch in CY26.
 "Sun Pharmaceutical: Domestic, innovation push eyed; Nuvama maintains 'Hold'")
Shilpa Medicare hits 5% upper circuit; here's what sparked the rally today
Around 1:30 PM, Shilpa Medicare shares continued to trade 2.04 per cent higher at ₹833.95 per share. In comparison, BSE Sensex was trading flat at 82,176.17 levels.
Natco Pharma surges 5% after USFDA classifies Hyderabad facility as VAI
Natco Pharma stock was trading at ₹884.5, up 3.2 per cent compared to the previous session's close of ₹857.25 on the NSE
 "Natco Pharma surges 5% after USFDA classifies Hyderabad facility as VAI")
Cohance Lifesciences shares slide 8% on block deals; Likely seller here
Cohance Lifesciences shares fell the most since August 14, after about 8.9 per cent stake changed hands on the NSE
 "Cohance Lifesciences shares slide 8% on block deals; Likely seller here")
Pharma in bitter health: Stocks sink upto 38% in 2025; time to bottom fish?
Among stocks, Natco Pharma plunged 37.85%, Ipca Labs 22.43%, Aurobindo Pharma 17.99%, and Sun Pharma 14.30%. Other laggards include Lupin (13.25%), and Dr Reddy's (5.17%).
 "Pharma in bitter health: Stocks sink upto 38% in 2025; time to bottom fish?")
Dr Reddy's shares fall as USFDA flags Hyderabad plant with 5 observations
Dr Reddy's shares fell on Monday after the USFDA issued a Form 483 with five observations at its Hyderabad plant inspection
 "Dr Reddy's shares fall as USFDA flags Hyderabad plant with 5 observations")
Blue Jet Healthcare down 4% as promoter launches OFS at ₹675; check details
Blue Jet Healthcare's share price was trading 3.55 per cent lower at ₹704.8 per share compared to previous day's close of ₹730 on the NSE
 "Blue Jet Healthcare down 4% as promoter launches OFS at ₹675; check details")
Laurus Labs gains 3%, nears record high; should you buy, hold or sell?
Thus far in September, the stock price of Laurus Labs has rallied 6 per cent, as compared to a 1.5 per cent rise in the BSE Sensex and BSE Healthcare index
 "Laurus Labs gains 3%, nears record high; should you buy, hold or sell?")
Glenmark Pharma up 3% on DCGI nod to start phase 3 trial of Envafolimab
Around 11:20 PM, Glenmark Pharmaceuticals shares continued to trade higher, up 3.05 per cent at ₹2,051.40 per share. In comparison, BSE Sensex was trading 0.25 per cent lower at 80,518.51 levels.
Biocon shares gain 2% after USFDA inspection at Bengaluru facility; details
The inspection covered various aspects of operations including drug substance manufacturing units, analytical quality control laboratories, microbiology laboratories, and warehouses
 "Biocon shares gain 2% after USFDA inspection at Bengaluru facility; details")
Pharma stock up 37% in 6 mths; Nuvama initiates with 'Buy', eyes 29% gains
According to Nuvama analysts Shrikant Akolkar, Aashita Jain and Gaurav Lakhotia, the company is positioned for robust growth over the medium-term, driven by capacity expansion and product additions.
Lupin share price rises 3% as USFDA okays schizophrenia drug; details
Drugmaker Lupin said it has received the USFDA's approval for Risperidone for extended-release injectable suspension
 "Lupin share price rises 3% as USFDA okays schizophrenia drug; details")
Anlon Healthcare makes flat D-street debut, lists at ₹92 on NSE SME
Post-listing, the Anlon Healthcare stock was trading at ₹91.5, up 0.55 per cent from the listing price on the BSE
 "Anlon Healthcare makes flat D-street debut, lists at ₹92 on NSE SME")